Kiniksa Pharmaceuticals Ltd reports results for the quarter ended in March - Earnings Summary

Kiniksa Pharmaceuticals International

23/04/2024 14:31

* Kiniksa Pharmaceuticals Ltd  KNSA.OQ  reported a quarterly
adjusted loss of 25 cents​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of -18 cents.  The mean expectation of
three analysts for the quarter was for a loss of 16 cents per
share. Wall Street expected results to range from -22 cents
to -13 cents per share.
    * Revenue rose 65.2% to $79.86 million from a year ago;
analysts
expected $78.46 million. 
    * Kiniksa Pharmaceuticals Ltd's reported EPS for the quarter
was a
loss of 25 cents​.
    * The company reported a quarterly loss of $17.7 million.
    * Kiniksa Pharmaceuticals Ltd shares had fallen by 13.4%
this
quarter and lost 2.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kiniksa
Pharmaceuticals Ltd is $29.00 
This summary was machine generated from LSEG data April 23 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.16          -0.25          Missed
 Dec. 31 2023      -0.14          0.35           Beat
 Sep. 30 2023      -0.17          -0.20          Missed
 Jun. 30 2023      -0.17          0.21           Beat